Debut Biotech is dedicated to unlocking natural products through sustainable biomanufacturing. Their unique biomanufacturing platform harnesses natural cell-free enzymes to overcome the limitations of cell-based manufacturing and provides access to previously unobtainable products. Debut Biotech truly believes that biomanufacturing will be how materials and ingredients are created in the future and is committed to leading the revolution.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/12/21 | $22,600,000 | Series A |
ACVC Ventures Cantos Ventures Cultivian Sandbox Venture Partners Fine Structure Ventures Humboldt Fund KdT Ventures Material Impact  | undisclosed |
| 10/19/23 | $40,000,000 | Series B |
BOLD | undisclosed |
